PFE - Pfizer advances development of once-daily weight-loss pill
2024-07-11 07:18:20 ET
Buoyed by encouraging pharmacokinetic data from an ongoing study, Pfizer ( NYSE: PFE ) has decided to proceed with the development of a once-daily formulation of its oral weight-loss drug, danuglipron....
Pfizer advances development of once-daily weight-loss pill